Reappraisal of Trifluperidol against NSP-3 as a potential therapeutic for COVID-19: molecular docking and dynamics study: Supplementary Figure 1–2.docx

Binding pattern of Deferasirox with ADRP. (A) Surface view of ADRP-Deferasirox complex. (B) Residue interaction diagram of Deferasirox with ADRP. (C) 2D interaction diagram of ADRP-Deferasirox interaction.

Supplementary Figure 2.

Binding pattern of Droperidol with ADRP. (A) Surface view of ADRP-Droperidol complex. (B) Residue interaction diagram of Droperidol with ADRP. (C) 2D interaction diagram of ADRP-Droperidol interaction.